News specifically tailored to medical oncologists
Initial results of NRG-LU001 indicate that, although the diabetes agent metformin was well-tolerated by patients,…
An analysis of data from the National Cancer Database found that after implementation of the…
An interim analysis of the international randomised, phase III ENZAMET trial found that 80% of…
A new blood test for women with breast cancer can predict how well patients will…
The randomised, phase III POLO trial found that maintenance therapy with the PARP inhibitor olaparib…
Nathan Bahary, University of Pittsburgh With Alex Trebek’s recent announcement that his pancreatic cancer is…
Immunotherapy is a revolutionary cancer treatment, but it was unknown if cancer patients with HIV…
A University of Colorado Cancer Center study presented at the American Society for Clinical Oncology…
Crizotinib and entrectinib are both active against ROS1 non-small cell lung cancer. But which is…
Neoadjuvant, or pre-surgical, treatment with nivolumab plus ipilimumab resulted in an overall major pathologic response…